SUI
Nicola von Lutterotti
President of the Board of Trustees, the Max-Planck Institute for Immunobiology and Epigenetics, Freiburg; Science Writer; Author, Germany
Self-employed

about me

Nicola von Lutterotti is the president of the board of trustees (since 2010) of the Max-Planck Institute for Immunobiology and Epigenetics in Freiburg and has advised them on the issues of public relations. She also supports other institutions like the Stiftung Humboldt Universität and the Stiftung Charité (both in Berlin) that promote innovations in science and the understanding of science. Besides, she is regularly writing for the newspapers FAZ and the NZZ and moderates medical conferences. After completing her Ph.D. on high blood pressure-treatment at the Medical Faculty of the University in Freiburg, Germany, she spent many years in this research field as postdoctoral Fellow at Cornell Medical University in New York City and the University of Milan, Italy. Early on, she noticed that much more emphasis is put on doing research than on communicating its results to the public. Therefore she already stared during her university studies to write about scientific topics in the lay press. She also served as press-officer of the German Cardiac Society (1995-2004).

more fellows

GBR
Helen Crimlisk
Sheffield Health & Social Care NHS Foundation Tr
Helen Crimlisk
Consultant Psychiatrist and Deputy Medical Director, Sheffield Health and Social Care NHS Foundation Trust, United Kingdom
SUI
Dunja Nicca
University of Zürich
Dunja Nicca
Research Group Leader and Head, Advanced Practices Nurses (APN), Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Switzerland
SUI
Oliver Reich
SWICA Health Organisation
Oliver Reich
Director, santé24, Switzerland
GER
Anna Babette Stier
Federal Ministry of Health
Anna Babette Stier
Head of Directorate for Health Protection and Sustainability, Federal Ministry of Health, Germany
SUI
Nicola von Lutterotti
Self-employed
Nicola von Lutterotti
President of the Board of Trustees, the Max-Planck Institute for Immunobiology and Epigenetics, Freiburg; Science Writer; Author, Germany
GBR
Lawrence Tallon
Guy's and St Thomas' NHS Foundation Trust
Lawrence Tallon
Chief Executive Officer, Medicines and Healthcare products Regulatory Agency, United Kingdom
SUI
Beatrice Beck Schimmer
University of Zürich
Beatrice Beck Schimmer
Full Professor of Anesthesiology and Vice President Medicine, University of Zürich (UZH), Switzerland
GBR
Judith Proctor
Edinburgh Integration Joint Board
Judith Proctor
Chief Officer, Edinburgh Integration Joint Board, Scotland, United Kingdom
GER
Marc Augustin
Protestant University of Applied Sciences
Marc Augustin
Professor, Protestant University of Applied Sciences Bochum, Germany
GER
Birgit Bauer
Manufaktur für Antworten UG
Birgit Bauer
Social Media & Digital Health Expert, Patient Expert, Journalist, Speaker, Manufaktur für Antworten UG, Germany
GBR
Rishi Das Gupta
Health Innovation Network (HIN)
Rishi Das Gupta
Chief Executive, Health Innovation Network (HIN), United Kingdom
SUI
Claudia Witt
University of Zurich
Claudia Witt
Professor of Medicine, University of Zurich; Director, Institute for Complementary and Integrative Medicine; University Hospital Zurich, Switzerland
GER
Wiebke Loebker
Federal Institute of Drugs and Medical Product
Wiebke Loebker
Personal Assistant of the President; Federal Institute of Drugs and Medical Products; Head of Innovation Office, Change Management Staff Unit, Germany
GBR
Rachel Carey
Zinc
Rachel Carey
Chief Missions and Science Officer, Zinc, United Kingdom
GER
Lorena Dini
Charité Universitätsmedizin Berlin
Lorena Dini
Senior Researcher, Charité Universitätsmedizin Berlin, Germany
SUI
Carl Rudolf Blankart
University of Bern
Carl Rudolf Blankart
Professor of Regulatory Affairs, University of Bern, Switzerland

Meet the Partners

Sciana: The Health Leaders Network is a programme supported jointly by the Health Foundation (UK), Careum (CH) and the Bosch Health Campus (DE) in collaboration with Salzburg Global.